CSP
ONC

Cary Street Partners’s BeOne Medicines Ltd ONC Stock Holding History

Cary Street Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
+986
New +$291K 0.01% 828

Other funds holding ONC

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
CST
Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Cary Street Partners's ONC Position: Q2 2026 in Review

Cary Street Partners opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 986 shares worth $281K. The stake represents 0.01% of the portfolio and ranks #828 among its holdings.

25 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Cary Street Partners held 986 shares of BeOne Medicines Ltd worth $281K as of Q2 2026.
  • BeOne Medicines Ltd was a new Cary Street Partners position in Q2 2026.
  • BeOne Medicines Ltd made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #828 holding.
  • 25 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.